Efficacy of Immune Checkpoint Inhibitors in Metastatic Melanoma (MM) Patients with Concurrent Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Guerra, Veronica [1 ]
Ologun, Gabriel [2 ]
Haydu, Lauren [2 ]
Keung, Emily [2 ]
Burton, Elizabeth [2 ]
Tawbi, Hussein [3 ]
Davis, Michael [3 ]
Wargo, Jennifer [2 ]
Ferrajoli, Alessandra [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
chronic lymphocytic leukemia; CLL; melanoma; immune checkpoint inhibitors; nivolumab; ipilimumab; pembrolizumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-229
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [31] Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
    Bol, Kalijn Fredrike
    Ellebaek, Eva
    Hoejberg, Lise
    Bagger, Mette Marie
    Larsen, Mathilde Skaarup
    Klausen, Tobias Wirenfeldt
    Kohler, Ulrich Heide
    Schmidt, Henrik
    Bastholt, Lars
    Kiilgaard, Jens Folke
    Donia, Marco
    Svane, Inge Marie
    CANCERS, 2019, 11 (10)
  • [32] Concurrent Radiosurgery and Immune Checkpoint Inhibition Improving Regional Intracranial Control for Patients With Metastatic Melanoma
    Murphy, Blair
    Walker, Joshua
    Bassale, Solange
    Monaco, Debra
    Jaboin, Jerry
    Ciporen, Jeremy
    Taylor, Matthew
    Kubicky, Charlotte Dai
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (03): : 253 - 257
  • [33] Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors
    Asher, Nethanel
    Marom, Edith M.
    Ben-Betzalel, Guy
    Baruch, Erez Nissim
    Steinberg-Silman, Yael
    Schachter, Jacob
    Shapira-Frommer, Ronnie
    Markel, Gal
    ONCOLOGIST, 2019, 24 (05) : 640 - 647
  • [34] The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case series
    Xizhi Wen
    Ya Ding
    Jingjing Li
    Jingjing Zhao
    Ruiqing Peng
    Dandan Li
    Baoyan Zhu
    Yao Wang
    Xing Zhang
    Xiaoshi Zhang
    Cancer Immunology, Immunotherapy, 2017, 66 : 1153 - 1162
  • [35] The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
    Lai-Kwon, Julia
    Khoo, Chloe
    Lo, Serigne
    Milne, Donna
    Mohamed, Mustafa
    Raleigh, Jeanette
    Smith, Kortnye
    Lisy, Karolina
    Sandhu, Shahneen
    Jefford, Michael
    JOURNAL OF CANCER SURVIVORSHIP, 2019, 13 (04) : 503 - 511
  • [36] NRAS tumor mutations are associated with reduced odds of dermatologic adverse events in patients with metastatic melanoma receiving immune checkpoint inhibitors
    Chang, Michael S.
    Said, Jordan T.
    Akama-Garren, Elliot H.
    Trepanowski, Nicole
    Bui, Ai-Tram N.
    Giobbie-Hurder, Anita
    Leboeuf, Nicole R.
    Hartman, Rebecca I.
    JAAD INTERNATIONAL, 2025, 18 : 165 - 167
  • [37] New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune-checkpoint inhibitors
    Ab Rahman, Ahmad Sufian
    Strother, Robert Matthew
    Paddison, Johanna
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (01) : 179 - 186
  • [38] Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma
    Tomsitz, Dirk
    Schlaak, Max
    Zierold, Sarah
    Pesch, Giulia
    Schulz, Thomas U.
    Mueller, Genoveva
    Zecha, Christine
    French, Lars E.
    Heinzerling, Lucie
    CANCERS, 2022, 14 (13)
  • [39] Efficacy of immune checkpoint inhibitors in patients with anorectal melanoma in association with immune-related adverse events: a case series
    Yokoyama, Reiko
    Sato, Yasushi
    Nakamura, Fumika
    Kagemoto, Kaizo
    Mitsui, Yasuhiro
    Okamoto, Koichi
    Kawano, Yutaka
    Sogabe, Masahiro
    Miyamoto, Hiroshi
    Takayama, Tetsuji
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2023, 16 (06) : 842 - 847
  • [40] Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors
    Kahn, Adriana M.
    Perry, Curtis J.
    Etts, Katrina
    Kluger, Harriet
    Sznol, Mario
    ONCOLOGIST, 2024, 29 (04) : e507 - e513
12345